PTAB To Review Claims In Novartis' Dementia Patch Patents
The U.S. Patent and Trademark Office's patent appeal board opted Tuesday to institute inter partes reviews of two Novartis AG patents covering its dementia treatment patch Exelon, finding petitioner Noven Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article